The impact of national guidelines on venom immunotherapy practice in the United Kingdom

Lavanya Diwakar, P. Ewan, P.A.J. Huber, A. Clark, S. Nasser, M T Krishna

    Research output: Contribution to journalArticlepeer-review

    6 Citations (Scopus)
    135 Downloads (Pure)

    Abstract

    Venom immunotherapy (VIT) is the only effective treatment for prevention of further anaphylactic reactions to bee and wasp stings in allergic individuals. A previous national survey carried out in 2006/2007 revealed significant heterogeneity in UK practice.The British Society for Allergy and Clinical Immunology (BSACI)
    guidelines for the diagnosis and management of hymenoptera venom (HV) allergy were subsequently published in 2011.This repeat survey was carried out to assess whether publication of BSACI guidelines helped improve the diagnosis and management of HV allergy in the UK National Health Service (NHS).
    Original languageEnglish
    Pages (from-to)749-753
    JournalClinical and Experimental Allergy
    Volume46
    Issue number5
    Early online date26 Apr 2016
    DOIs
    Publication statusPublished - May 2016

    Keywords

    • Allergy and Immunology
    • Immunotherapy
    • Hymenoptera
    • Anaphylaxis
    • national guidelines

    Fingerprint

    Dive into the research topics of 'The impact of national guidelines on venom immunotherapy practice in the United Kingdom'. Together they form a unique fingerprint.

    Cite this